MedPath

The Predictors for Continuous Renal Replacement Therapy in Liver Transplant Patient

Completed
Conditions
Liver Transplantation
Registration Number
NCT01457534
Lead Sponsor
Yonsei University
Brief Summary

Background. Acute renal failure after liver transplantation (LT) requiring continuous renal replacement therapy (CRRT) adversely affects patient survival. However, there are few reports to assess the predictors for postoperative CRRT in liver transplant patients. The investigators undertook this study to identify perioperative factors that would predict patients at risk of CRRT.

Patients and Methods. The investigators retrospectively reviewed the data of 148 liver transplant patients from January 2007 to November 2010 at Severance Hospital, Yonsei University HealthSystem, in Seoul, Korea. The number of patients treated with CRRT was 44 (18 patients from living and 26 from deceased donors) and those without CRRT was 104. Univariate and stepwise logistic multivariate analyses were performed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
148
Inclusion Criteria
  • Age 19-65 year
  • Liver transplant patients from January 2008 to December 2011
Exclusion Criteria
  • Patients treated with CRRT before transplantation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
status before operation1 day before operation

laboratory data(ex : total bilirubin, albumin, coagulation factors, blood gas analysis(arterial CO2 pressure. Blood urea nitrate/Creatinine, Hemoglobin/Hematocrit.)

the amount of ascitesintraoperative
the duration of anesthesia and operationintraoperative
intraoperative hemodynamic instabilityintraoperative
intraoperative bleedingintraoperative
Intraoperative urine outputintraoperative
the types of donation(living or deceased donor)intraoperative
survival rateon the postoperative 28th days, 365 days
postoperative bleeding amounton the postoperative 28th days, 365 days.
postoperative CRRT(continuous renal replacement therapy),on the postoperative 28th days, 365days
mortalityon the postoperative 28th days, 365 days.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Severance Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath